Home » Topics » BioWorld Science

BioWorld Science
RSS

Janssen Pharmaceutica NV synthesizes 5-HT2B receptor antagonists

Sep. 4, 2018

I-Mab Biopharma presents anti-CD73 antibodies for cancer

Sep. 4, 2018

TACI found to have prognostic value in heart failure

Sep. 4, 2018

MedImmune patents new fusion proteins for heart failure

Sep. 4, 2018

Kodiak completes enrollment in phase I study of KSI-301 in diabetic macular edema

Sep. 4, 2018

XPO5 gene polymorphism found to protect from coronary artery disease risk

Sep. 4, 2018

In rare encephalitis, neurons contribute to their own demise

Sep. 4, 2018

Dogs and Duchenne

Sep. 4, 2018

Filoviruses hide out in sperm production site

Sep. 4, 2018

AstraZeneca conducts first-in-human study of AZD-8154 in healthy subjects

Sep. 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...